This order aims to restrict access to gender-affirming care for people under age 19, affecting overall access to healthcare for transgender, gender diverse, and intersex young people. It also promotes the criminalization of parents and healthcare providers involved in accessing care. Even though many provisions will require guidance or rulemaking to implement, and enforcement has been blocked by a federal judge, many providers have already stopped providing some or all gender-affirming care to young people out of fear.
Executive Office of the President - White House Office
A directive issued by the President that manages operations of the federal government. Executive orders have the force of law but must align with existing statutes and constitutional authority.
Who It Impacts: Federal agencies and employees, directing them on how to implement laws or carry out government functions. Executive orders can also influence businesses and individuals when they relate to issues like immigration, trade, or labor policies.
Who Is Not Impacted: Private citizens and businesses do not have to directly follow an executive order unless it leads to regulations or policies that apply to them. For example, an executive order directing federal agencies to increase renewable energy use does not mandate action from private companies, but it may influence policy shifts that eventually affect them.
Date Enacted
January 28, 2025
Last Updated
May 30, 2025
Policy Type
Healthcare Coverage
Healthcare Delivery, Services & Quality
LGBTQI+ Health
Summary
This order provides a definition of “chemical and surgical mutilation” that is intended to encompass all forms of health care that is commonly referred to as gender-affirming care for an individual under 19. It directs specific actions to limit healthcare, including stopping insurance support, reviewing policies, and requiring this policy for all federally funded organizations.
Impact Analysis
Legal Challenges
PFLAG, INC., et al v. Trump et al (D.Md.)
Take Institutional Action
Health systems and providers should continue to provide essential and culturally competent medical care for their patients, regardless of sexual orientation or gender identity. Health systems should review HIPPA and confidentiality policies to clarify any ambiguity about the privacy rights of institutions patients. Providers should proactively engage their patients who depend on gender-affirming care and seek to understand any impacts they may be experiencing. Healthcare institution should review state non-discrimination laws and ensure provided care is aligned with those protections. Institutions can also engage in health equity coalition building and remain engaged in discussions about how best to navigate the complexities of providing appropriate care.
Associated or Derivative Policies
Additional Resources
National Health Law Program: President Trump's Initial Executive Actions Threaten Sexual and Reproductive Health (https://healthlaw.org/president-trumps-initial-executive-actions-threaten-sexual-and-reproductive-health/)
Winston & Strawn: Current Status of White House Executive Order on Gender-Affirming Care (https://www.winston.com/en/insights-news/current-status-of-white-house-executive-order-on-gender-affirming-care)
KFF's Analysis on President Trump's Executive Order on Gender Affirming Care (https://www.kff.org/policy-watch/president-trumps-executive-order-on-gender-affirming-care-responses-by-providers-states-and-litigation/)
